title: Restless legs syndrome.
authors.affiliation: Department of Clinical Neurological Sciences, London Health Sciences Centre, Western University, London, Ont. philippe.rizek@trilliumhealthpartners.ca.
authors.forename: Philippe
authors.initials: P
authors.lastname: Rizek
authors.affiliation: Department of Clinical Neurological Sciences, London Health Sciences Centre, Western University, London, Ont.
authors.forename: Niraj
authors.initials: N
authors.lastname: Kumar
mesh_terms: D000740:Anemia / Q000453:epidemiology; D000927:Anticonvulsants / Q000627:therapeutic use*; D002110:Caffeine / Q000009:adverse effects; D002492:Central Nervous System Depressants / Q000009:adverse effects; D000697:Central Nervous System Stimulants / Q000009:adverse effects; D015928:Cognitive Behavioral Therapy; D018450:Disease Progression; D018491:Dopamine Agonists / Q000627:therapeutic use*; D000431:Ethanol / Q000009:adverse effects; D005081:Exercise Therapy; D006801:Humans; D051436:Renal Insufficiency, Chronic / Q000453:epidemiology; D012148:Restless Legs Syndrome / Q000139:chemically induced / Q000453:epidemiology / Q000628:therapy*; D000070263:Sleep Hygiene
chemical_list: D000927:Anticonvulsants; D002492:Central Nervous System Depressants; D000697:Central Nervous System Stimulants; D018491:Dopamine Agonists; D002110:Caffeine; D000431:Ethanol